• U.S. market leading monthly issuance at $430 million in 49 deals
• Canada brings 57 deals to market for C$414 million
By Stephanie N. Rotondo
Portland, Ore., April 30 - The level of private placements taking place in the U.S. market in April remained significantly lower than activity for the same period of 2008, as well as for the prior month, according to data compiled by Prospect News.
For April, U.S. issuers completed 49 deals totaling $430 million. That compares to 75 deals for a total of $7.06 billion in March.
Year to date, issuers have brought 249 deals to market, bringing in $16.59 billion. By this time in 2009, 385 U.S. deals had been brought to market, raising a total of $43.26 billion.
Among U.S. issuers, Lazard continues to be the top underwriter, placing one deal during the month for a total of $31 million. Lazard also leads in year-to-date deals, placing three deals for $155 million.
A large number of private placements have no underwriter. In other cases, the underwriters are not disclosed.
Among U.S. direct placements, Leerink Swann holds the top spot, with $46 million in one deal, accounting for 17.56% of the transactions for the year.
In the Canadian marketplace, C$414 million in 57 deals came in April. Year to date, Canadian companies have participated in 198 deals for a total of C$1.81 billion.
Like the U.S. market, Canadian deals have lagged behind March levels, as well as levels seen in 2008. In March, 58 deals totaling $355 million came to market, while in April 2008, there were 102 deals, bringing in C$15.43 billion.
RBC Capital Markets earned the top spot for Canadian underwriters in April, with C$24 million in three deals. Year to date, the Macquarie Group has brought in C$94 million in three deals, accounting for 5.18% of the year's issuance.
Year to date, U.S. market
2008 Comparables
| Underwriter | Amount | No. | Share | Rank | Amount | No. | Share
|
1 | Lazard | 0.155 | 3 | 0.94% | 6 | 0.088 | 2 | 0.20%
|
2 | Octagon Capital | 0.066 | 1 | 0.40% |
|
3 | Union Securities | 0.065 | 1 | 0.39% |
|
4 | JPMorgan | 0.060 | 1 | 0.36% | 14 | 0.026 | 1 | 0.06%
|
5 | RBC | 0.052 | 1 | 0.31% |
|
6 | Pritchard Capital | 0.048 | 1 | 0.29% |
|
7 | Rodman & Renshaw | 0.027 | 2 | 0.16% | 2 | 0.118 | 11 | 0.27%
|
8 | Canaccord | 0.026 | 2 | 0.16% | 10 | 0.033 | 2 | 0.08%
|
9 | Jesup & Lamont | 0.025 | 3 | 0.15% |
|
10 | APIX International | 0.020 | 1 | 0.12% |
|
| Total | 16.590 | 249 | 43.262 | 385 |
|
|
|
| Average size: | 0.067 | 0.112 |
|
|
|
April, U.S. market
|
| | | | | 2008 Comparables
|
| Underwriter | Amount | No. | Share | Rank | Amount | No. | Share
|
1 | Lazard | 0.031 | 1 | 7.22% |
|
2 | Rodman & Renshaw | 0.012 | 1 | 2.79% | 4 | 0.056 | 3 | 0.36%
|
3 | Garden State Securities | 0.006 | 1 | 1.37% |
|
4 | Genesis Capital | 0.003 | 1 | 0.61% |
|
5 | Non-brokered | 0.002 | 1 | 0.53% |
|
| Total | 0.430 | 49 | 15.431 | 102 |
|
|
|
| Average size: | 0.009 | 0.151 |
|
|
|
Year to date, U.S. direct placements
|
| | | | | 2008 Comparables
|
| Underwriter | Amount | No. | Share | Rank | Amount | No. | Share
|
1 | Leerink Swann | 0.046 | 1 | 17.56% |
|
2 | Rodman & Renshaw | 0.045 | 5 | 17.31% | 2 | 0.151 | 7 | 33.60%
|
3 | Piper Jaffray | 0.014 | 3 | 5.59% | 4 | 0.040 | 1 | 8.91%
|
4 | Roth Capital | 0.010 | 2 | 3.80% |
|
5 | Emerging Growth Equities | 0.008 | 1 | 3.18% |
|
6 | Philadelphia Brokerage | 0.007 | 1 | 2.70% |
|
7 | Oppenheimer | 0.004 | 1 | 1.42% |
|
| Total | 0.259 | 18 | 0.449 | 17 |
|
|
|
| Average size: | 0.014 | 0.026 |
|
|
|
Year to date, Canadian market
|
| | | | | 2008 Comparables
|
| Underwriter | Amount | No. | Share | Rank | Amount | No. | Share
|
1 | Macquarie | 0.094 | 3 | 5.18% | 36 | 0.011 | 2 | 0.23%
|
2 | TD | 0.056 | 3 | 3.10% | 29 | 0.018 | 1 | 0.37%
|
3 | RBC | 0.051 | 2 | 2.82% | 6 | 0.131 | 2 | 2.78%
|
4 | Ocean Equities | 0.050 | 1 | 2.77% |
|
5 | GMP | 0.050 | 1 | 2.77% | 8 | 0.082 | 9 | 1.75%
|
6 | Canaccord | 0.039 | 9 | 2.17% | 5 | 0.237 | 21 | 5.05%
|
7 | Dundee | 0.035 | 5 | 1.95% | 26 | 0.020 | 3 | 0.42%
|
8 | Primary Capital | 0.033 | 2 | 1.83% | 34 | 0.013 | 2 | 0.28%
|
9 | CIBC | 0.027 | 1 | 1.49% | 3 | 0.775 | 4 | 16.49%
|
10 | GMP Securities | 0.025 | 1 | 1.38% | 25 | 0.023 | 4 | 0.48%
|
| Total | 1.808 | 198 | 4.700 | 383 |
|
|
|
| Average size: | 0.009 | 0.012 |
|
|
|
April, Canadian market
|
| | | | | 2008 Comparables
|
| Underwriter | Amount | No. | Share | Rank | Amount | No. | Share
|
1 | RBC | 0.024 | 1 | 5.80% |
|
2 | Dundee | 0.019 | 1 | 4.70% | 7 | 0.020 | 3 | 2.94%
|
3 | TD | 0.017 | 1 | 4.04% |
|
4 | Primary Capital | 0.015 | 1 | 3.63% |
|
5 | National Bank Financial | 0.015 | 1 | 3.63% |
|
6 | Canaccord | 0.013 | 3 | 3.16% | 3 | 0.077 | 3 | 11.44%
|
7 | Raymond James | 0.010 | 1 | 2.42% |
|
8 | Octagon | 0.008 | 1 | 1.93% |
|
9 | Macquarie | 0.008 | 1 | 1.89% | 11 | 0.011 | 2 | 1.63%
|
10 | Maison Placements | 0.007 | 1 | 1.78% | 13 | 0.010 | 1 | 1.49%
|
| Total | 0.414 | 57 | 0.674 | 92 |
|
|
|
| Average size: | 0.007 | 0.007 |
|
|
|
|
Prospect News PIPE Underwriter Rankings
|
|
Criteria
• The tables include all dollar-denominated offerings (or Canadian dollar-denominated offerings for the Canadian tables) sold as private placements, excluding Rule 144A deals, or direct placements.
• Stock must be listed on a U.S. exchange or trade on the Bulletin Board or Pink Sheets (U.S. issues).
• Offerings are included in the time period in which they price, if known, otherwise by settlement date or announcement date.
• Amounts are based on the total sales price (face amount or number of shares multiplied by the offering price).
• Each tranche is counted as a separate deal.
• Includes stock, securities convertible into stock, units of these securities and equity lines of credit.
• Minimum issue size $1 million (all tranches combined) or C$1 million.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.